Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers
Clinical trial NCT01389466 · COMPLETED
Trial details
- NCT number
- NCT01389466
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-11-01
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.